Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series por George Ansstas, David D. Tran

Enlace del recurso

553 Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma por George Ansstas, Renee Morecroft, Jordan Phillipps

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma por Karam Khaddour, Tanner M Johanns, George Ansstas

Enlace del recurso

The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions por Karam Khaddour, Tanner M. Johanns, George Ansstas

Enlace del recurso

Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma por Karam Khaddour, Alice Zhou, Omar Butt, Jiayi Huang, George Ansstas

Enlace del recurso

Where Are We Now with Oncolytic Viruses in Melanoma and Nonmelanoma Skin Malignancies? por George Nassief, Angela Anaeme, Karen Moussa, David Chen, George Ansstas

Enlace del recurso

Induced Remission of Metastatic Squamous Cell Carcinoma with an Immune Checkpoint Inhibitor in a Patient with Recessive Dystrophic Epidermolysis Bullosa por Karam Khaddour, Emily S. Gorell, Farrokh Dehdashti, Jean Y. Tang, George Ansstas

Enlace del recurso

Metachronous cutaneous squamous cell carcinoma in a young patient as the only presenting symptom to uncover Lynch syndrome with MLH1 Germline mutation por Karam Khaddour, Ryan C. Fields, Michael Ansstas, Ilana S. Rosman, George Ansstas

Enlace del recurso

Recent Advancements in Cell-Based Therapies in Melanoma por George Nassief, Angela Anaeme, Karen Moussa, Abdallah N. Mansour, George Ansstas

Enlace del recurso

Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma por Renee Morecroft, Jordan Phillipps, Alice Zhou, Omar Butt, Karam Khaddour, Tanner Johanns, George Ansstas

Enlace del recurso

Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome por Karam Khaddour, Amy Musiek, Lynn A. Cornelius, Farrokh Dehdashti, Peter Westervelt, Ryan Fields, George Ansstas

Enlace del recurso

180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma por Ari VanderWalde, Andrew Elliott, George Ansstas, Soo Park, Kevin Kim, George P Souroullas, Tolulope Adeyelu

Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios por Karam Khaddour, Karam Khaddour, Alice Zhou, Omar H. Butt, Griffin Budde, Allyson Koyen Malashevich, George Ansstas

Enlace del recurso

Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification por George Nassief, BA, Omar H. Butt, MD, PhD, Alice Y. Zhou, MD, PhD, George Ansstas, MD

Enlace del recurso

Homologous Recombination Deficiency (HRD) in Cutaneous Oncology por Favour A. Akinjiyan, Renee Morecroft, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Soo J. Park, Omar H. Butt, Alice Y. Zhou, George Ansstas

Enlace del recurso

Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma por Jordan Phillipps, George Nassief, Renee Morecroft, Tolulope Adeyelu, Andrew Elliott, Farah Abdulla, Ari Vanderwalde, Soo Park, Omar Butt, Alice Zhou, George Ansstas

Enlace del recurso

Objective response to immune checkpoint inhibitor therapy in NRAS-mutant melanoma: A systematic review and meta-analysis por Zachary J. Jaeger, Neel S. Raval, Natalia K. A. Maverakis, David Y. Chen, David Y. Chen, George Ansstas, Angela Hardi, Lynn A. Cornelius, Lynn A. Cornelius

Enlace del recurso

ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes por Favour A. Akinjiyan, George Nassief, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Farah Abdulla, Alice Y. Zhou, George Souroullas, Kevin B. Kim, Ari Vanderwalde, Soo J. Park, George Ansstas

Enlace del recurso

BRAF mutations may identify a clinically distinct subset of glioblastoma por Samantha N. McNulty, Katherine E. Schwetye, Cole Ferguson, Chad E. Storer, George Ansstas, Albert H. Kim, David H. Gutmann, Joshua B. Rubin, Richard D. Head, Sonika Dahiya

Enlace del recurso

Durable melanoma control following disseminated talimogene laherparepvec herpetic infection por Leonid Shmuylovich, MD, PhD, Aubriana M. McEvoy, MD, MS, Ryan C. Fields, MD, Leonel Hernandez-Aya, MD, George Ansstas, MD, David Y. Chen, MD, PhD

Enlace del recurso